Srihari Vedartham has over 15+ years of experience with Profit and Loss responsibility for the business development and product development efforts; a deal sheet of over 10+ transactions (>$700M) and raising over $100M of financing through deal making and new product planning efforts. Successful specialty drug launch experience – Atryn, Xenazine, Sabril, and Onfi. Demonstrated expertise and success in starting companies from the ground up. Experience working in organizations both small (~20 employees) and large (~6,000 employees WW). Sriharis holds a Master in Organic Chemistry from Osmania University in India and an MBA from Tennessee Tech University.
Current role